The Social Cost of Wellness: New NIH Visitor Guidelines Threaten Immigrant Patients
The arrival of 2025 saw the inauguration of Donald Trump for his second term and his Administration’s takeover of the federal government. The confirmation of Robert F. Kennedy Jr. as Health Secretary means that the Trump Administration is positioned to impose its policy choices on all aspects of the federal government under […]
The Regression of Drug Policy in Trump’s Punitive Approach to Substance Use
In an effort to handle what he has stated as a “rampant drug smuggling and overdose death” problem in the United States, Trump has confirmed that new 25 percent tariffs will go into effect on March 4th against Mexico and Canada, with an additional 10 percent tariff against China. Despite a nearly 24 […]
The Future of Medicaid: How Proposed Budget Cuts Could Reshape Healthcare for Millions
Medicaid, the largest health insurance program in the country, provides coverage to over 72 million low-income individuals, people with disabilities, and the elderly. It covers one in five Americans and funds almost half of all births in the United States. Medicaid is also administered by the states and jointly funded by the states and the federal government. […]
PBMs, Their Controversy, and Their Future
The debate of whether pharmacy benefit managers (PBMs) are necessary in the healthcare field has been ongoing for years and doesn’t seem to be slowing down. PBMs are essentially middlemen and act as negotiating entities in the prescription drug supply chain. PBMs have the opportunity to set the prices of drugs in […]
Public Health at Risk: A Look at the New Administration’s Actions Against Vaccines
On February 15, 2025, Robert F. Kennedy Jr. was confirmed to be President Trump’s secretary of the Department of Health and Human Services (“HHS”). HHS, among other things, oversees disease prevention through the Centers for Disease Control and Prevention (CDC); oversees the safety of food, drugs, medical devices, and vaccines through the Food and […]